Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Sanofi mulls buyout of Insmed and its Brinsupri: Bloomberg
A purchase of Insmed would equip Sanofi with the approved Brinsupri, well on its way to blockbuster status in familiar respiratory territory.
Fraiser Kansteiner
Nov 19, 2026 2:10pm
Regulatory tracker: Sanofi lands EC nod for next-gen rabies vaccine
Nov 20, 2026 2:40pm
Merck scores US, German wins over Halozyme on Keytruda Qlex
Nov 20, 2026 2:07pm
Mapping psychedelics’ commercial summit
Nov 20, 2026 1:38pm
Fierce Biotech
Merck’s TROP2 ADC extends survival in pivotal cancer trial
Nov 20, 2026 11:20am
The Oral GLP-1 Tracker: Foundayo stead, Wegovy pill scripts drop
Nov 20, 2026 10:50am
More News
Novo set to cut another 215 jobs tied to its New Jersey HQ
Nov 20, 2026 10:49am
FDA establishes new CBER safety council for approved biologics
Nov 20, 2026 10:45am
Ivonescimab, Pfizer, gene trial penalty—Fierce Pharma Asia
Nov 20, 2026 10:00am
Sanofi wins FDA OK with first GD3 drug to treat neuro decline
Nov 20, 2026 9:30am